Project

ACRODAT

Aborted · 2021 until 2025

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2021
End Date
2025
Financing
Industry
Brief description/objective

Post-marketing surveillance study to evaluate the clinical utility of ACRODAT® in an international, multicentre, randomised, non-interventional study